{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:42:50Z","timestamp":1778899370220,"version":"3.51.4"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007644","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000}}],"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19-AI-56578"],"award-info":[{"award-number":["U19-AI-56578"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007644","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T17:09:12Z","timestamp":1566407352000},"page":"e0007644","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis"],"prefix":"10.1371","volume":"13","author":[{"given":"Theresa B.","family":"Gallagher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8299-5958","authenticated-orcid":true,"given":"Gabriela","family":"Mellado-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-7317","authenticated-orcid":true,"given":"Stephen","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Nataro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Les W.","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"issue":"1","key":"pntd.0007644.ref001","article-title":"Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens","volume":"9","author":"Y Fan","year":"2017","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"2","key":"pntd.0007644.ref002","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1574-695X.2011.00800.x","article-title":"The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax","volume":"62","author":"KE Brenneman","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"10","key":"pntd.0007644.ref003","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1517\/14712598.4.10.1661","article-title":"DNA vaccines against anthrax","volume":"4","author":"DR Galloway","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"pntd.0007644.ref004","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tim.2014.02.012","article-title":"Anthrax lethal and edema toxins in anthrax pathogenesis","volume":"22","author":"S Liu","year":"2014","journal-title":"Trends Microbiol"},{"issue":"32","key":"pntd.0007644.ref005","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1016\/j.vaccine.2007.05.018","article-title":"Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine","volume":"25","author":"MJ Hepburn","year":"2007","journal-title":"Vaccine"},{"issue":"41","key":"pntd.0007644.ref006","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1016\/j.vaccine.2010.07.075","article-title":"An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor","volume":"28","author":"LW Baillie","year":"2010","journal-title":"Vaccine"},{"issue":"33\u201334","key":"pntd.0007644.ref007","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial","volume":"24","author":"GJ Gorse","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"pntd.0007644.ref008","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1586\/14760584.2013.814860","article-title":"Anthrax vaccines: present status and future prospects","volume":"12","author":"M Kaur","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"pntd.0007644.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12044","article-title":"Protecting against plague: towards a next-generation vaccine","volume":"172","author":"ED Williamson","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"pntd.0007644.ref010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/08998280.2005.11928049","article-title":"Plague: from natural disease to bioterrorism","volume":"18","author":"S. Riedel","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"16","key":"pntd.0007644.ref011","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"P Russell","year":"1995","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"pntd.0007644.ref012","doi-asserted-by":"crossref","first-page":"D56","DOI":"10.1016\/j.vaccine.2009.07.068","article-title":"Plague","volume":"27","author":"ED Williamson","year":"2009","journal-title":"Vaccine"},{"issue":"5748","key":"pntd.0007644.ref013","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1118476","article-title":"The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles","volume":"310","author":"CA Mueller","year":"2005","journal-title":"Science"},{"issue":"3","key":"pntd.0007644.ref014","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.70.3.1453-1460.2002","article-title":"Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis","volume":"70","author":"Y Du","year":"2002","journal-title":"Infect Immun"},{"issue":"6","key":"pntd.0007644.ref015","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"ED Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"10","key":"pntd.0007644.ref016","doi-asserted-by":"crossref","first-page":"e0004162","DOI":"10.1371\/journal.pntd.0004162","article-title":"Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination","volume":"9","author":"A Derbise","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"36","key":"pntd.0007644.ref017","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1016\/j.vaccine.2010.06.054","article-title":"Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice","volume":"28","author":"JN Brewoo","year":"2010","journal-title":"Vaccine"},{"issue":"47","key":"pntd.0007644.ref018","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/j.vaccine.2016.09.063","article-title":"Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague","volume":"34","author":"PM Arnaboldi","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"pntd.0007644.ref019","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1128\/IAI.73.8.5256-5261.2005","article-title":"Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens","volume":"73","author":"A Glynn","year":"2005","journal-title":"Infect Immun"},{"issue":"29\u201330","key":"pntd.0007644.ref020","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1016\/j.vaccine.2011.04.084","article-title":"Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague","volume":"29","author":"ED Williamson","year":"2011","journal-title":"Vaccine"},{"issue":"16","key":"pntd.0007644.ref021","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.vaccine.2007.01.071","article-title":"Development of a recombinant vaccine against aerosolized plague","volume":"25","author":"SR Morris","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"pntd.0007644.ref022","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1080\/21645515.2016.1160977","article-title":"The promise and challenge of epitope-focused vaccines","volume":"12","author":"J. Oscherwitz","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"pntd.0007644.ref023","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molimm.2015.07.019","article-title":"Priyanka, Joon S, Sinha S, Bhatnagar R. Investigation of a panel of monoclonal antibodies and polyclonal sera against anthrax toxins resulted in identification of an anti-lethal factor antibody with disease-enhancing characteristics","volume":"68","author":"P Kulshreshtha","year":"2015","journal-title":"Mol Immunol"},{"issue":"6","key":"pntd.0007644.ref024","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/IAI.72.6.3276-3283.2004","article-title":"Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages","volume":"72","author":"N Mohamed","year":"2004","journal-title":"Infect Immun"},{"issue":"52","key":"pntd.0007644.ref025","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1016\/j.vaccine.2009.07.015","article-title":"Protection against anthrax and plague by a combined vaccine in mice and rabbits","volume":"27","author":"J Ren","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"pntd.0007644.ref026","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.PLAS-0028-2014","article-title":"Using Plasmids as DNA Vaccines for Infectious Diseases","volume":"2","author":"JS Tregoning","year":"2014","journal-title":"Microbiol Spectr"},{"issue":"7062","key":"pntd.0007644.ref027","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"E Meylan","year":"2005","journal-title":"Nature"},{"issue":"21","key":"pntd.0007644.ref028","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1016\/j.vaccine.2005.08.031","article-title":"DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components","volume":"24","author":"UK Hahn","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"pntd.0007644.ref029","doi-asserted-by":"crossref","first-page":"e0139671","DOI":"10.1371\/journal.pone.0139671","article-title":"Enhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge","volume":"10","author":"NY Kim","year":"2015","journal-title":"PLoS One"},{"issue":"21","key":"pntd.0007644.ref030","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.vaccine.2009.03.011","article-title":"Small protective fragments of the Yersinia pestis V antigen","volume":"27","author":"C Vernazza","year":"2009","journal-title":"Vaccine"},{"issue":"39","key":"pntd.0007644.ref031","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2010.12.062","article-title":"Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge","volume":"29","author":"S Wang","year":"2011","journal-title":"Vaccine"},{"issue":"23\u201324","key":"pntd.0007644.ref032","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/S0264-410X(02)00232-3","article-title":"Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague","volume":"20","author":"ED Williamson","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"pntd.0007644.ref033","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1574-695X.2012.00974.x","article-title":"Immunogenicity and efficacy of an anthrax\/plague DNA fusion vaccine in a mouse model","volume":"65","author":"MT Albrecht","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"10","key":"pntd.0007644.ref034","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.it.2017.07.012","article-title":"DNA Sensing across the Tree of Life","volume":"38","author":"S Gallucci","year":"2017","journal-title":"Trends Immunol"},{"issue":"1","key":"pntd.0007644.ref035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/IAI.00788-08","article-title":"Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies","volume":"77","author":"ML Nguyen","year":"2009","journal-title":"Infect Immun"},{"issue":"2","key":"pntd.0007644.ref036","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1286-4579(99)80004-5","article-title":"Molecular pathogenesis of Bacillus anthracis infection","volume":"1","author":"SF Little","year":"1999","journal-title":"Microbes Infect"},{"issue":"2","key":"pntd.0007644.ref037","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.femsim.2004.05.011","article-title":"Characterization of the human immune response to the UK anthrax vaccine","volume":"42","author":"L Baillie","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"7","key":"pntd.0007644.ref038","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.4049\/jimmunol.0901581","article-title":"Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes","volume":"184","author":"RJ Ingram","year":"2010","journal-title":"J Immunol"},{"issue":"8","key":"pntd.0007644.ref039","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/AAC.49.8.3414-3420.2005","article-title":"Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694","volume":"49","author":"E Laffly","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pntd.0007644.ref040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1997.56.471","article-title":"Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis","volume":"56","author":"GW Anderson","year":"1997","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"pntd.0007644.ref041","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/IAI.66.2.615-619.1998","article-title":"Anthrax toxin-mediated delivery in vivo and in vitro of a cytotoxic T-lymphocyte epitope from ovalbumin","volume":"66","author":"JD Ballard","year":"1998","journal-title":"Infect Immun"},{"issue":"14","key":"pntd.0007644.ref042","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1073\/pnas.97.14.8027","article-title":"Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity","volume":"97","author":"Y Lu","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"pntd.0007644.ref043","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0923-2494(93)80102-5","article-title":"Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cells","volume":"144","author":"P Sarobe","year":"1993","journal-title":"Res Immunol"},{"issue":"21","key":"pntd.0007644.ref044","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1016\/j.vaccine.2005.08.033","article-title":"pDNAVACCultra vector family: high throughput intracellular targeting DNA vaccine plasmids","volume":"24","author":"JA Williams","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"pntd.0007644.ref045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molmed.2009.04.003","article-title":"Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines","volume":"15","author":"JD Ahlers","year":"2009","journal-title":"Trends Mol Med"},{"issue":"37","key":"pntd.0007644.ref046","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1016\/j.vaccine.2010.06.089","article-title":"Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies","volume":"28","author":"K Ramirez","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"pntd.0007644.ref047","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cimid.2012.10.005","article-title":"Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain","volume":"36","author":"G Mellado-Sanchez","year":"2013","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"48","key":"pntd.0007644.ref048","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1016\/j.vaccine.2008.09.010","article-title":"Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy","volume":"26","author":"LW Baillie","year":"2008","journal-title":"Vaccine"},{"issue":"9","key":"pntd.0007644.ref049","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.4049\/jimmunol.176.9.5671","article-title":"Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies","volume":"176","author":"AV Capozzo","year":"2006","journal-title":"J Immunol"},{"issue":"1\u20132","key":"pntd.0007644.ref050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2008.01.007","article-title":"Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization","volume":"333","author":"H Li","year":"2008","journal-title":"J Immunol Methods"},{"issue":"1","key":"pntd.0007644.ref051","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/IAI.74.1.794-797.2006","article-title":"Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen","volume":"74","author":"KK Peachman","year":"2006","journal-title":"Infect Immun"},{"key":"pntd.0007644.ref052","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3389\/fimmu.2017.00687","article-title":"A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis","volume":"8","author":"P Tao","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"pntd.0007644.ref053","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vaccine.2015.11.025","article-title":"Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen-The first step toward a rationally designed anthrax vaccine","volume":"34","author":"RC McComb","year":"2016","journal-title":"Vaccine"},{"issue":"33","key":"pntd.0007644.ref054","doi-asserted-by":"crossref","first-page":"30936","DOI":"10.1074\/jbc.M301154200","article-title":"Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody","volume":"278","author":"MJ Rosovitz","year":"2003","journal-title":"J Biol Chem"},{"key":"pntd.0007644.ref055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2018.1486154","article-title":"One Year Immunogenicity and Safety of Subunit Plague Vaccine in Chinese Healthy Adults: An Extended Open-Label Study","author":"J Hu","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"pntd.0007644.ref056","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1128\/IAI.73.8.5152-5159.2005","article-title":"LcrV plague vaccine with altered immunomodulatory properties","volume":"73","author":"KA Overheim","year":"2005","journal-title":"Infect Immun"},{"issue":"1","key":"pntd.0007644.ref057","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/JB.117.1.48-55.1974","article-title":"Characterization of the antigenic subunits of the envelope protein of Yersinia pestis","volume":"117","author":"LG Bennett","year":"1974","journal-title":"J Bacteriol"},{"key":"pntd.0007644.ref058","unstructured":"https:\/\/asprtracie.hhs.gov\/technical-resources\/67\/mass-distribution-and-dispensing-of-medical-countermeasures\/60."},{"issue":"21","key":"pntd.0007644.ref059","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1016\/j.vaccine.2005.08.066","article-title":"Engineering of needle-free physical methods to target epidermal cells for DNA vaccination","volume":"24","author":"M. Kendall","year":"2006","journal-title":"Vaccine"},{"key":"pntd.0007644.ref060","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01263691."}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007644","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0007644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T04:58:37Z","timestamp":1610859517000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007644"}},"subtitle":[],"editor":[{"given":"Abdallah M.","family":"Samy","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007644","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0007644","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,20]]}}}